Jasper de Boer

7PUBLICATIONS
33CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersHaematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 17, 2024
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor.

Sandra Cantilena, Mohamed AlAmeri, Noelia Che

|Apr 13, 2024
Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.

Jasper de Boer, Rebecca Barnett, Anthony Cardin

|Mar 25, 2024
Clinical activity in general practice before sarcoma diagnosis: an Australian cohort study.

Meena Rafiq, Jasper de Boer, Jasmine Mar

|Jun 22, 2022
Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.

Sandra Cantilena, Luca Gasparoli, Deepali Pal

|Apr 03, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.

Katherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli

|Aug 12, 2021
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation.

Stefanie Meier, Sandra Cantilena, Maria Victoria Niklison Chirou

Pageof 2